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RESEARCH ARTICLE

Modulation of PTZ-induced convulsions in rats using topiramate alone or
combined with low dose gamma irradiation: involving AKT/m-TOR pathway
Dina M. Lotfya, Marwa M. Safarb,c, Seham H. M. Hassana and Sanaa A. Kenawyb
a
Department of Drug Radiation Research, National Centre for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo,
Egypt; bDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt; cDepartment of Pharmacology
and Biochemistry, The British University in Egypt, Cairo, Egypt

ABSTRACT

ARTICLE HISTORY

The current study evaluates the anticonvulsant effect low dose whole body gamma irradiation (LDR)
alone or combined with topiramate against pentylenetetrazole (PTZ)-induced convulsions. Male Wister
rats received either saline or PTZ (75 mg/kg i.p.). The other three groups were pretreated with single
low dose radiation (0.5 Gy), topiramate (50 mg/kg, p.o., seven days) and TPM with LDR respectively
before PTZ injection. Racine’ score, latency, and duration of the convulsions were assessed. Glutamate
and GABA were measured. AKT/m-TOR signaling pathway including AKT (protein kinase B), mammalian
target of rapamycin (m-TOR), protein S6, and caspase 3 were also assessed. Measurements of markers
of oxidative stress including malondialdehyde (MDA), glutathione (GSH), and nitric oxide (NO) were
carried out. Histological examinations of hippocampi were done. PTZ produced behavioral changes
(high Racine score, short latency, and long duration). It elevated MDA and NO contents, while reduced
GSH content. TPM treatment alone or combined with LDR ameliorated the PTZ-induced convulsions
and caused significant improvement in behavioral changes, brain mediators, m-TOR pathway, oxidative
stress, and histological pictures in hippocampal regions. Histopathological examinations of the normal
group showed normal structure with intact cells, while PTZ-treated rats exhibited necrosis, pyknosis,
and atrophy of pyramidal cells. The histological findings corroborated with the amendment of biochemical parameters. The positive effects of LDR could offer a possible contributor in management of
convulsions due to modulation of AkT/m-TOR signaling pathway, reduction of oxidative stress and
modulation of brain amino acids. LDR improved the oxidative stress side effects of topiramate.
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1. Introduction
The mammalian target of rapamycin (m-TOR) is a 290-kDa
serine–threonine protein kinase that is highly conserved
among mammals (Sandsmark et al. 2007). Physiologic regulation of the m-TOR signaling pathway suggested controlling
downstream effectors such as ribosomal protein S6, which
regulate protein synthesis and other processes related to cellular growth, proliferation, metabolism, and survival. In
response to environmental and physiological stimuli,
upstream pathways, primarily involving cascades of protein
kinases, may either activate Akt/m-TOR. In anabolic process,
such as with insulin, growth factor, or nutrient stimulation,
PI3K/Akt activates the m-TOR pathway and induces protein
synthesis, cell growth, and proliferation. Conversely, catabolic
states (hypoxia) inhibit the m-TOR pathway and thus slowing
protein synthesis, cell growth, and metabolism (Wong 2010).
Acquired brain injuries may cause abnormal activation of mTOR and related pathways, which may lead to cellular and
molecular changes promoting convulsions (Zhang and Wong
2012). Determining the pathophysiological significance of the
mTOR pathway in convulsions is complicated by the fact
that seizures themselves appear to activate m-TOR, thus
CONTACT Dina M. Lotfy
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potentially triggering a circular, progressive process.
Pentylenetetrazole (PTZ) is an antagonist of gamma-aminobutyric acid receptors that induces acute convulsions in
rodents . Thus, the PTZ model is used to illustrate the direct
effects of convulsions on m-TOR pathway. Low dose radiation activates the host defensive which is confirmed by
reduction in lipid peroxidation and elevation of glutathione
(GSH) content (Shibrya et al. 2017). LDR may contribute to
counteract the hyper activation of m-TOR pathway by
decreasing lipid peroxidation and increasing GSH.
Abnormal regulation of m-TOR pathway by various effectors such as PTZ, genetic mutation, and traumatic brain
injury leads to hyperactivity of protein kinase B (AKT) and mTOR resulting in an increase in protein synthesis and oxidative stress (Figure 1).
Topiramate (TPM) is a novel, broad spectrum, antiepileptic
drug with a reported protective effect against several brain
injuries (Yong et al. 2015). Its mechanisms of action include
blockade of the sodium and calcium channels (DeLorenzo et
al. 2000), as well as inhibition of the ionotropic glutamate
receptors
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA)/kainate. This study aimed to
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The radiation source was Cs137 using a Canadian Gamma
Cell (GC-40, Nordion-Canada, Ottawa, Canada), belonging to
the National Centre for Radiation Research and Technology
(NCRRT) at Cairo, Egypt. The gamma caesium cell was calibrated by alanine dosimetry relative to a primary standard.

2.4. Induction of convulsions
Figure 1. Abnormal regulation of AKT/m-TOR pathway. (þ) enhance,
(") increase.

investigate the effect of administration of topiramate alone
or combined with low dose of whole body c-irradiation in
PTZ-induced acute model of convulsions in rats.

2. Materials and methods
2.1. Animals
Adult male Wistar rats (180–200 g) were obtained from
Institute of Ophthalmology (Giza, Egypt). Rats were housed
in plastic cages (28 cm  43 cm  18 cm) for at least one
week in the laboratory room prior to testing. Animals were
kept under conventional laboratory conditions throughout
the study. They were allowed free access to food consisting
of standard pellets chow (El-Nasr Chemical Co., Cairo, Egypt)
and water ad libitum. All animals’ procedures were performed in accordance to the guideline ethics of committee
for animal experimentations of Faculty of Pharmacy, Cairo
University (PT no. 1676) and in compliance with regulations
of the ethical committee for animal care at the NCRRT,
Egyptian Atomic Energy Authority, Cairo, Egypt.
Convulsion induction was done between 9:00 am and
12:00 pm to minimize circadian influences on seizure
susceptibility.

2.2. Treatments
Rats were allocated into five groups (number rats in each
group ¼ 6), group I received saline and served as normal
control. Group II received single intraperitoneal PTZ (SigmaAldrich, St. Louis, MO) injection in dose of 75 mg/kg (Zhang
and Wong 2012) and served as control. Group III was
exposed to low dose whole body c-irradiation (0.5 Gy) 24 h
before PTZ administration. Groups IV was treated with topiramate (TOP; Sun Pharma, Ahmedabad, India) daily in a dose
of 50 mg/kg p.o. for seven days (Armagan et al. 2008) and
group V received topiramate (50 mg/kg p.o.) for seven consecutive days and rats were exposed to a single dose of
c-irradiation (0.5 Gy) on the 6th day, then rats were injected
with PTZ (75 mg/kg) on the 7th day. PTZ and topiramate
were dissolved in saline.

2.3. Irradiation of animals
Rats were exposed to whole body c-radiation at a single
dose level of 0.5 Gy delivered at a dose rate of 0.43 Gy/min.

Convulsions were induced chemically by single intraperitoneal dose of PTZ at a dose level of 75 mg/kg (Zhang and
Wong 2012).

2.5. Seizures assessment and tissue sampling
After PTZ injection, rats were placed singly in cages then
latency (min) and duration of convulsions were observed for
30 min. Severity of convulsions was scored according to
Racine’s score as follows (Racine 1972):
Rats were euthanized by decapitation under light ether
anesthesia after convulsions assessment and brain hippocampi were dissected for biochemical analysis and histopathological examination (six hippocampi of each group
were used for biochemical analysis).

2.6. Determination of brain amino acids by
ELISA technique
Glutamate and GABA contents (lmol/g tissue) were estimated in hippocampi by ELISA technique using commercially
available kits (glutamate, Abnova, Walnut, CA), (GABA, ELAaab) according to manufacturer’s instructions.

2.7. Determination of malondialdehyde (MDA)
colorimetrically
Malondialdehyde content was determined in hippocampi via
the estimation of thiobarbituric acid-reactive substances
(TBARS) based on the reaction of tissue MDA with thiobarbituric acid to produce a pink pigment that was extracted by
n-butanol and measured colorimetrically at 535 nm.
Hippocampal TBARS contents were then expressed as nanomole per gram wet tissue according to the method
described by Ohkawa et al. (1979).

2.8. Determination of glutathione colorimetrically
Hippocampal reduced GSH content was determined using a
test reagent kit according to the method of Beutler et al.
(1963). The method is based on the reduction of 5,50 -dithiobis(2-nitrobenzoic acid) with GSH to produce a yellow color.
The reduced chromogen was measured colorimetrically at
405 nm and GSH content was expressed as microgram per
gram wet tissue.

TOXICOLOGY MECHANISMS AND METHODS

2.9. Determination of nitric oxide (NO) colorimetrically
Brain tissue (hippocampus) NO colorimetric assay was performed in hippocampi using a test reagent kit according to
the method of Montgomery and Dymock (1961). This assay
determines NO content based on enzymatic conversion of
nitrate to nitrite by nitrate reductase. The reaction is followed by a colorimetric detection of nitrite as an azo dye
product produces NO2– which reacts with sulfanilic acid to
produce diazonium ion. This ion is then coupled to N-(1naphthyl) ethylene diamine to form the chromophoric azoderivative, which absorbs light at 540 nm.

2.10. Akt, m-TOR, and caspase 3 gene expression by
PCR technique
Total RNA was extracted from hippocampal tissue using
RNeasy Kit (Qiagen, Valencia, CA), and the purity of the
obtained RNA was verified spectrophotometrically at 260/
280 nm. Equal amounts of RNA (2 mg) were reverse transcribed into complementary DNA (cDNA) using Superscript
Choice systems (Life Technologies, Carlsbad, CA) according
to the manufacturer’s guidelines. To assess the expression of
AKT, m-TOR, and caspase 3 genes, quantitative real-time PCR
was performed using SYBR Green PCR Master Mix (Applied
Biosystems, Foster City, CA) as described by the manufacturer. Briefly, in a 25-ll reaction volume, 5 ll of cDNA was
added to 12.5 ll of 2 SYBR Green Master Mix, and 200 ng
of each primer. The sequences of primers are described in
Table 1. PCR reactions included 10 min at 95  C for activation
of AmpliTaq Gold DNA polymerase, followed by 40 cycles at
95  C for 15 s (denaturing) and 60  C for 1 min (annealing/
extension). The relative expression of target genes was
obtained using the 2DDCT formula using GAPDH as a housekeeping gene.
Protein S6 content was measured using ELISA technique
according to manufacturer’s instructions.
The relative quantitation was calculated according to
applied bio system software using the following equation:
DCtðcyclethresholdÞ
¼ Cttestedgene –Ctreferencegene ðhousekeepingÞ
DDCt ¼ DCtsample –Ctcontrol
RelativequantificationðRQÞ ¼ 2ðDDCtÞ
The RQ is the fold change compared to the control.

2.11. Histopathological examination using
light microscope
Brain hippocampi were dissected and fixed in neutral buffered formalin processed by conventional method,
embedded in paraffin, sectioned at 4–5 mm and stained by
hematoxylin and eosin (H&E) for standard histological examination using light microscope according to the method of
Banchroft et al. (1996).

2.12. Statistical analysis
Data were expressed as means ± SEM, and comparisons
between means were carried out using one-way ANOVA followed by Tukey–Kramer’s multiple comparisons test. A probability value of less than 0.05 was accepted as statistically
significant.

3. Results
Table 2 depicts that rats subjected to PTZ exhibited convulsions with 1.10-min average seizure latency. Exposure of rats
to low dose whole body c-radiation alone or combined with
TOP showed a significant increase in latency and tendency
to protect against convulsions. The anticonvulsant potential
of TOP was enhanced by exposure of animals to low dose
gamma radiation. Rats showed no convulsions; these effects
were significant from the antiepileptic drug alone. Compared
to PTZ group, exposure of rats to low dose whole body
c-radiation (0.5 Gy) exhibited a significant decrease in glutamate content by 29% (Figure 2) and significantly increased
GABA contents by 414% (Figure 3). Topiramate significantly
decreased glutamate by 22% (Figure 2) compared to PTZcontrol. Treatment of rats with topiramate alone or
Table 2. Effect of administration of topiramate alone or combined with low
dose whole body gamma irradiation on Racine’s stage score, latency and duration in PTZ-induced acute model of convulsions in rats.
Groups
PTZ (75 mg/kg i.p.)
c-IRR (0.5 Gy)þPTZ
TOP (50 mg/kg p.o.)þPTZ
c-IRR þ TOP þ PTZ

Racine’s score

Latency (min)

Duration (min)

5.00 ± 0.00
2.00@±0.00
1.33@±0.42
0.00@±0.00

1.10 ± 0.10
1.17 ± 0.17
1.30 ± 0.12
0.00@±0.00

13.67 ± 1.15
0.00@±0.00
0.00@±0.00
0.00@±0.00

PTZ: pentylenetetrazole; c-IRR: gamma irradiation; TOP: topiramate.
Racine’s score as follows: (0) normal. (1) Mouth and facial movements, hyperactivity, grooming, sniffing, scratching, wet dog shakes. (2) Tremor. (3)
Forelimb clonus, forelimb extension. (4) Rearing, salivating, tonic clonic activity. (5) Falling, status epilepticus.
Data for Racine’s score, latency and durations are expressed as means of
6 rats ± SEM.
@p < 0.05 compared to PTZ group using one-way ANOVA followed by
Tukey–Kramer’s multiple comparisons test.

Table 1. The sequence of primers used for real-time PCR analysis.
Gene symbol
AKT
m-TOR
Caspase-3
GAPDH

3

Primer sequence
F: 50 -CGGATACCATGAACGACGTAG-30
R: 50 -GCAGGCAGCGGATGATAAAG-30
F: 50 -ACGAAGGAGACAGACCGAAG-30
R: 50 -CGACGAAGTCACTAGATTCA-30
F: 50 -GATCACAGCAAAAGGAGCAGT-30
R: 50 -CTACTCCACTGTCTGTCTCAAT-30
F: 50 -CACCCTGTTGCTGTAGCCATATTC-30
R: 50 -GACATCAAGAAGGTGGTGAAGCAG-30

Gene bank accession number
NM_033230.2
AM_943028.1
NM_012922.2
XM_017592435.1
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Figure 2. Effect of administration of topiramate (TOP; 50 mg/kg p.o.) alone or
combined with low dose whole body gamma irradiation (IRR; 0.5 Gy) on brain
glutamate content in PTZ-induced acute model of convulsions in rats. Data represent the mean % of 6 animals. Statistical analysis was carried out by one-way
ANOVA followed by Tukey–Kramer’s multiple comparisons test. Significantly
different from normal group at p < 0.05. @Significantly different from PTZ
group at p < 0.05.

Figure 5. Effect of administration of topiramate alone or combined with low
dose whole body gamma irradiation on brain mammalian target of rapamycin
(m-TOR) gene expression in PTZ-induced acute model of convulsions in rats.

Figure 6. Effect of administration of topiramate alone or combined with low
dose whole body gamma irradiation on brain ribosomal protein S6 gene
expression in PTZ-induced acute model of convulsions in rats.
Figure 3. Effect of administration of topiramate (TOP; 50 mg/kg p.o.) alone or
combined with low dose whole body gamma irradiation (IRR; 0.5 Gy) on brain
GABA content in PTZ-induced acute model of convulsions in rats.

Figure 7. Effect of administration of topiramate alone or combined with low
dose whole body gamma irradiation on brain caspase 3 gene expression in
PTZ-induced acute model of convulsions in rats.
Figure 4. Effect of administration of topiramate alone or combined with low
dose whole body gamma irradiation on brain protein kinase B (AKT) gene
expression in PTZ-induced acute model of convulsions in rats.

combined with low dose whole body c-irradiation significantly increased GABA content by 514% and 1550% respectively compared to PTZ-control (Figure 3). PTZ injection
caused a corresponding activation of the m-TOR pathway in
the rat hippocampus, as reflected by an increase in the AKT
by 31% (Figure 4), m-TOR by 82% (Figure 5) and protein S6
by 717% (Figure 6). The AKT/m-TOR pathway’ parameters,

however, were significantly decreased in all treated groups.
PTZ significantly increased caspase 3 by 259% (Figure 7).
TOP alone or combined with c-IRR significantly decreased
caspase 3 contents by 91% and 92% respectively as compared to PTZ-control group (Figure 7). PTZ showed significant increase in brain MDA by 177% (Figure 8) and NO by
123% (Figure 9) accompanied with depletion of GSH content
by 65% (Figure 10). The antioxidant parameters, however,
were reinstated in all treated groups. Histological examinations were in line with the tested parameters (Figure 11).

TOXICOLOGY MECHANISMS AND METHODS

Figure 8. Effect of administration of topiramate alone or combined with low
dose whole body gamma irradiation on brain MDA content in PTZ-induced
acute model of convulsions in rats.

Figure 9. Effect of administration of topiramate alone or combined with low
dose whole body gamma irradiation on brain NO content in PTZ-induced acute
model of convulsions in rats.

Figure 10. Effect of administration of topiramate alone or combined with low
dose whole body gamma irradiation on brain GSH content in PTZ-induced acute
model of convulsions in rats.

4. Discussion
In the current study, acute administration of PTZ (75 mg/kg,
i.p.) was associated with behavioral changes manifested as
high stage of Racine’s score, long duration and short latency
of convulsions compared to the normal control group. These
results are in accordance with the findings of Rajabzadeh et
al. (2012) (acute single dose of PTZ 60–100 mg/kg, i.p. or
s.c.), Saha et al. (2014) (chronic administration of PTZ day
after day at a dose level of 40 mg/kg i.p.) and Hussein et al.
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(2016). These results may be due to that: PTZ is a central
nervous system stimulant that is thought to act at the
gamma aminobutyric receptor (Aksoy et al. 2014) (PTZ
70 mg/kg i.p.). The mechanism of inhibition of GABA receptors seems to be competitive with respect to GABA in both
rat and human (Ren et al. 2001 who used PTZ at a dose level
50 mg/kg i.p.).
In the present study, acute administration of PTZ (75 mg/
kg i.p.) revealed a decline in the brain GABA. These results
are in agreement with those of Safar et al. (2010). However,
McCandless and Schwartzenburg (1982) and Kondziella et al.
(2002) stated that PTZ administration at dose level of 45 mg/
kg i.p. either increased or did not alter GABA contents.
Acute administration of PTZ (75 mg/kg i.p.) resulted in
non-significant difference in the brain glutamate contents.
These results are in coincide with the results of Safar et al.
(2010) who reported that PTZ (45 mg/kg i.p.) treatment had
no effect on glutamate contents. While Rothman and Olney
(1995) stated that PTZ enhanced the glutamenergic system.
Furthermore, Kherani and Auer (2008) also showed that PTZ
(50 mg/kg i.p.) significantly increased glutamate contents.
Vasil’ev et al. (2014) demonstrated that acute administration
of PTZ (45 mg/kg i.p.) caused excessive activation of glutamate receptors.
In the current study, administration of acute dose of PTZ
(75 mg/kg i.p.) significantly activated Akt/m-TOR signaling
pathway. These results are in agreement with the results of
Zhang and Wong (2012) (PTZ 75 mg/kg i.p.). AKT/m-TOR signaling pathway regulates multiple cellular functions that may
contribute to convulsions, including protein synthesis, cell
growth, and proliferation, as well as synaptic plasticity
(Zhang and Wong 2012).
The present results showed that acute administration of
PTZ (75 mg/kg i.p.) induced apoptotic cell death illustrated
by the significant increase in caspase-3 activity, suggesting a
link between neuronal loss and behavioral disturbances
observed in the rats. These results are in line with those of
Muhammad et al. (2011) (PTZ 50 mg/kg i.p.).
The present results showed that, PTZ (75 mg/kg, i.p.)
induced oxidative stress biomarkers. These results were manifested as elevation of MDA and NO contents, as well as
decline of GSH content compared to normal group. The present results that showed a significant increase in the generation of MDA contents coincide with the findings of
Bashkatova et al. (2003) in cerebral cortex, Patsoukis et al.
(2004a, 2004b) in hippocampus, and Ilhan et al. (2005) in
whole brain after acute PTZ induced convulsions (PTZ 60 mg/
kg i.p.) and in plasma of epileptic patients (Sudha et al.
2001). Experimental convulsions are known to be associated
with a massive release of reactive oxygen species. Indeed an
increase in lipid peroxidation has been reported in the
hippocampus and cerebral cortex of rodents following PTZinduced acute and chronic convulsions (Ono et al. 2000;
Mueller et al. 2001; Haggag et al. 2014).
The effect of pentylenetetrazole on NO content is consistent with other studies of Lipton et al. (1993), Bashkatova et
al. (2003), Bikjdaouene et al. (2003), and Ilhan et al. (2005).
These findings may be attributed to that, PTZ induced Ca2þ
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Figure 11. Photomicrograph of hippocampus of normal rat showing normal histological structure with intact cells and normal cerebral blood vessels (I), photomicrograph of hippocampus of PTZ rat showing necrosis, pyknosis and atrophy of pyramidal cells (II), photomicrograph of hippocampus of irradiated rat þ PTZ
showing normal histological structure with intact cells and normal cerebral blood vessels (III), photomicrograph of hippocampus of rat treated with
topiramate þ PTZ showing normal histological structure with intact cells and normal cerebral blood vessels (IV), photomicrograph of hippocampus of irradiated rat
pretreated with topiramate þ PTZ showing normal histological structure with intact cells and normal cerebral blood vessels (V). Arrows in the (II) show necrosis,
pyknosis and atrophy of pyramidal cells.

influx, thus activating Ca2þ/calmodulin-dependent neuronal
nitric oxide synthase (n NOS) (Bikjdaouene et al. 2003).
Depletion of GSH by acute administration of PTZ in this
study is in line with the results of Patsoukis et al. (2004a,
2004b, 2005). These results may be attributed to cysteine
deprivation caused by glutamate binding to the disulfide
cystine transporter (Bannai and Kitamura 1980). This inverse
correlation between GSH and PTZ was highlighted by the
study of Abe et al. (1999), who showed that PTZ convulsions
were inhibited by the exogenous administration of this thiol.
In the present study, histopathological examinations of
brain hippocampi showed that, PTZ-induced seizure (75 mg/
kg i.p.) significantly increased neuronal death. These results
are in accordance with the results of Rowbotham et al.
(1998) and Bloom (2004) who demonstrated that PTZ was
documented to provoke excessive Ca2þ influx generating
reactive oxygen and nitrogen species which both lead to
neuronal cell death. Furthermore, Vasil’ev et al. (2014) and
Muhammad et al. (2011) showed that, the histopathological
examinations of brain hippocampi after PTZ administration
(50mg/kg i.p.) significantly increased neuronal death. These
results may be due to the accumulation of m-TOR content
which participates in brain atrophy including focal cortical
dysplasia and acquired brain injuries (Wong 2010) (PTZ
75 mg/kg i.p.).
The present study demonstrated the neuroprotective
effects of the low dose whole body gamma irradiation
(0.5 Gy) against PTZ-induced convulsions (75 mg/kg i.p.),

manifested as a significant decrease in Racine’s stage score
and duration of convulsions associated with prolongation of
convulsions latency.
In the current study, single exposure to low dose whole
body gamma radiation (0.5 Gy) significantly decreased glutamate content, while significantly increased GABA content
compared to PTZ-control group. These results may be attributed to modulation of central neurotransmitter systems and
might be attributed to inhibition of monoamine oxidase
activity in the cerebral cortex, cerebellum, and hippocampus.
Liang et al. (2006) demonstrated that a low dose of whole
body gamma irradiation of mice (LDR 0.5 Gy) resulted in neuroprotection against l-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP)-mediated damage of striatal dopaminergic nerve
fibers hence cause nerve protection.
Exposure to acute low dose whole body gamma radiation
(0.5 Gy) downregulated the present AKT/m-TOR signaling
pathway resulting in recovery of the induced convulsions
caused by PTZ and also resulted in neuroprotection against
brain cell damaging effects; this protection might be attributed to protection of hippocampi. Moreover, Shibrya et al.
(2017) reported that the neuroprotective effect of low dose
whole body c-irradiation (LDR 0.5 Gy) could modulate the
central monoaminergic neurotransmitter systems.
The current investigation pointed to the antioxidant capacity of low dose whole body gamma irradiation (0.5 Gy).
Exposure to low dose gamma radiation attenuated the PTZinduced elevation in MDA content and NO content as well

TOXICOLOGY MECHANISMS AND METHODS

as depletion in GSH content in brain tissues. These findings
were consistent with a previous report of Nomura et al.
(2002) who showed that whole body gamma irradiation
(0.5 Gy) increased the antioxidant substances such as GSH in
various organs of normal mice, and lowered the lipid peroxide contents. These results may be due to an increase in the
expression of m-RNA for c-glutamylcysteine synthase, a ratelimiting enzyme in GSH synthesis (Kawakita et al. 2003)
(LDR 0.5 Gy).
Accordingly, Liang et al. (2006) suggested several mechanisms for the neuroprotection induced by low dose gamma
irradiation (LDR 0.5 Gy): increased in GSH contents, the activation of immune function and enzymatic DNA repair
induced by radiation hormesis. In the present study, an
increase in brain GSH content as a result of radiation was
shown in rats exposed to whole body c-radiation alone.
Moreover, Kipnis et al. (2004) reported that the low dose
c-irradiation was accompanied by an increased incidence of
activated T cells, leading to an accumulation of self-reactive
T cells in the injured central nervous system and
neuroprotection.
The present topiramate administration (50 mg/kg p.o.) significantly decreased Racine’s stage score and convulsions
latencies compared to PTZ-control group. These results coincide with the results of Renata et al. (2000) who stated that,
topiramate did not influence minimal convulsions.
Current treatment with topiramate (50 mg/kg p.o.)
showed downregulation of AKT/m-TOR signaling pathway
resulting in recovery of the induced convulsions caused by
pentylentetrazole. Topiramate treatment (50 mg/kg p.o.)
showed a significant decrease in MDA content compared to
PTZ-control group. These results coincide with the results of
Armagan et al. (2008) who used topiramate at dose level of
50 and 100 mg/kg p.o. and Muriach et al. (2010). These
results may be due to that, topiramate is an effective neuroprotectant in acute PTZ-induced convulsions by regulating
neuronal inflammation and neuronal cell death (Yong et al.
2015). Topiramate administration (50 mg/kg p.o.) significantly
increased GSH content compared to PTZ-control. These
results are in line with the results of Cardile et al. (2002) and
Agarwal et al. (2011) who reported the positive regulatory
effect of topiramate on the antioxidant system as a significant increase in GSH content has been observed. Cardenas
et al. (2013) demonstrated that the scavenging activity of
topiramate might explain its neuroprotective properties.
Topiramate (50 mg/kg p.o.) has protective effects by inhibition of free radicals and by support of the antioxidant redox
system (Armagan et al. 2008). Topiramate provides protection against oxidative damage as reflected by reduced lipid
peroxidation and increased reduced GSH contents (Narin et
al. 2017) (TOP 40 mg/kg p.o.).
Topiramate (50 mg/kg p.o.) protections against oxidative
damage, as shown in animal models of epilepsy, might be
directly due to antioxidant properties of topiramate and
indirectly due to other mechanisms of action (Cardenas et al.
2013; Nazıroglu and Yurekli 2013) (TOP 40 mg/kg p.o.).
The present results revealed that topiramate administration (50 mg/kg p.o.) alone showed normal hippocampal
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histological structure with normal, intact cells and blood vessels. These results are in line with the results of Maschio et
al. (2007). Narin et al. (2017) demonstrated the neuroprotective role of topiramate in spinal cord injury (TOP 45 mg/kg
p.o.). Topiramate is considered as a well-documented neuroprotective AMPA receptor antagonist (Gensel et al. 2012).
Combination between topiramate (50 mg/kg p.o.) and low
dose whole body gamma irradiation (0.5 Gy) in the present
experiments showed normal behavioral assessments, significant increased GABA and GSH contents compared to PTZcontrol group. However, this combination significantly
decreased AKT, m-TOR, protein S6, MDA, and NO contents
compared to PTZ-control group. These results confirmed
positive effects of low dose gamma irradiation which may be
related to the modulation of amino acids, AKT/m-TOR pathway and the redox status, and hence could be of value in
the management of convulsions.

5. Conclusions
The current findings are in line with the anticonvulsive
effects of LDR which could offer a possible contributor in
management of convulsions. This effect might be due to
modulation of AkT/m-TOR signaling pathway, reduction of
oxidative stress and modulation of brain amino acids. LDR
improved the oxidative stress status after topiramate treatment.
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